Personalized treatment for Graves and certain thyroid cancers
Part of Cancer, Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a personalized approach to treat thyroid disorders, either Graves’ disease or certain thyroid cancers that may need radioactive iodine treatment. It may help by matching treatment to your specific test results and needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have either confirmed Graves’ disease (shown by lab tests) or certain thyroid cancer
- Your thyroid cancer must be “intermediate” or “high risk” and may need radioactive iodine to treat remaining neck disease
- You can understand and follow instructions in simple English
- You do not have a serious neck/neck-spine problem like arthritis or severe degenerative disease
- You are not pregnant, and you are able to understand simple instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.
This trial tests whether adding iodine supplements to standard antithyroid medication can help people with Graves' hyperthyroidism get their thyroid levels under control more quickly. It may be an option for those who are newly diagnosed or have not yet achieved normal thyroid levels with medication alone.
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
This study compares computer-guided dosing of methimazole (a common thyroid medication) to standard care for people with active Graves' disease. It tests whether digital support helps manage treatment better.
This early-phase trial tests a new type of treatment called CAR-T cells (special immune cells made in a lab) to target and calm down the overactive immune system in people with severe Graves' disease that hasn't improved with standard medicines. It may offer a new option for those who have been on treatment for years or have had multiple relapses.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.